Search Results - "Talks, James"

Delayed follow-up of medical retina patients due to COVID-19: impact on disease activity and visual acuity by Stone, Lydia G., Grinton, Michael E., Talks, James S.

“…Purpose The coronavirus pandemic has prompted unprecedented delays to treatment with anti-VEGF intravitreal injections due to the need to reduce hospital…”
Get full text

Should we still be performing macular laser for non-centre involving diabetic macular oedema? No by Mueller, Isabella, Talks, James S.

Get full text

First-Year Visual Acuity Outcomes of Providing Aflibercept According to the VIEW Study Protocol for Age-Related Macular Degeneration by Talks, James S., MRCP, FRCOphth, Lotery, Andrew J., MD, FRCOphth, Ghanchi, Faruque, FRCOphth, Sivaprasad, Sobha, FRCOphth, Johnston, Robert L., FRCOphth, Patel, Nishal, MD, FRCOphth, McKibbin, Martin, FRCOphth, Bailey, Clare, FRCOphth, Mahmood, Sajjad, FRCOphth

“…Purpose Aflibercept has the potential advantage of reducing capacity problems by allowing 2 monthly visits for patients with neovascular macular degeneration…”
Get full text

Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19 by Stone, Lydia G., Devenport, Adele, Stratton, Irene M., Talks, James S.

“…Purpose To assess the treatment position of all patients who have had an anti-VEGF injection in 2020, prior to the UK lockdown on 23 March. To assess methods…”
Get full text

Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence by Daien, Vincent, Finger, Robert P, Talks, James S, Mitchell, Paul, Wong, Tien Y, Sakamoto, Taiji, Eldem, Bora M, Korobelnik, Jean-François

“…The aim of this work was to evaluate the contribution of real-world evidence (RWE) in changing anti-vascular endothelial growth factor (VEGF) therapy treatment…”
Get more information

Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations by Kodjikian, Laurent, Parravano, Mariacristina, Clemens, Andreas, Dolz-Marco, Rosa, Holz, Frank G., Munk, Marion R., Nicolò, Massimo, Ricci, Federico, Silva, Rufino, Talks, S. James, Verma, Rohini Kumar, Zarranz-Ventura, Javier, Zweifel, Sandrine A.

“…Current guidelines on the management of patients with neovascular age-related macular degeneration (nAMD) lack clear recommendations on the interpretation of…”
Get full text

Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems by Finger, Robert P, Daien, Vincent, Eldem, Bora M, Talks, James S, Korobelnik, Jean-Francois, Mitchell, Paul, Sakamoto, Taiji, Wong, Tien Yin, Pantiri, Krystallia, Carrasco, Joao

“…Systematically review the evidence describing the impact of anti-vascular endothelial growth factor (anti-VEGF) therapy on neovascular age-related macular…”
Get full text

Multiple Evanescent White Dot Syndrome and Choroidal Neovascularization following SARS-COV-2 Infection in a Patient on Dabrafenib and Trametinib by Gallo, Beatrice, Talks, James S., Pandit, Ranjeet J., Browning, Andrew C.

“…to describe multimodal imaging and electrophysiology of multiple evanescent white dot syndrome (MEWDS) concomitant with COVID-19 infection in a patient on BRAF…”
Get full text

Stakeholder Perspectives of Clinical Artificial Intelligence Implementation: Systematic Review of Qualitative Evidence by Hogg, Henry David Jeffry, Al-Zubaidy, Mohaimen, Talks, James, Denniston, Alastair K, Kelly, Christopher J, Malawana, Johann, Papoutsi, Chrysanthi, Teare, Marion Dawn, Keane, Pearse A, Beyer, Fiona R, Maniatopoulos, Gregory

“…The rhetoric surrounding clinical artificial intelligence (AI) often exaggerates its effect on real-world care. Limited understanding of the factors that…”
Get full text

Sickle Eye Project: a cross-sectional, non-interventional study of the prevalence of visual impairment due to sickle cell retinopathy and maculopathy in the UK by Dinah, Christiana, Balaskas, Konstantinos, Greystoke, Brigit, Awadzi, Rossby, Beke, Peter, Ahern, Roger, Talks, James

“…IntroductionSickle cell disease (SCD) is one of the most common genetic disorders in the UK, with over 15 000 people affected. Proliferative sickle cell…”
Get full text

Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy - a systematic approach to identify and characterize data sources by Daien, Vincent, Eldem, Bora M, Talks, James S, Korobelnik, Jean-Francois, Mitchell, Paul, Finger, Robert P, Sakamoto, Taiji, Wong, Tien Yin, Evuarherhe, Obaro, Carter, Gemma, Carrasco, Joao

“…Real-world data (RWD) has been a valuable addition to the scientific literature regarding treatment pathways, clinical outcomes and characteristics of patients…”
Get full text

Real-World Visual and Neovascularisation Outcomes from anti-VEGF in Central Retinal Vein Occlusion by Hogg, H. D. Jeffry, Talks, S. James, Pearce, Mark, Di Simplicio, Sandro

“…Central retinal vein occlusion (CRVO) can be complicated by macular oedema, requiring intravitreal injection (IVI) of anti-vascular endothelial growth factor…”
Get full text

Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab by Talks, S. James, Bhatia, Devangna, Menon, Geeta, Cole, Abosede, Eleftheriadis, Haralabos, Downey, Louise, Chong, Ngai Victor, Sivaprasad, Sobha

“…Background Diabetic macular oedema (DMO) is effectively treated with ranibizumab but multiple injections are required. Where there is also peripheral…”
Get full text

The use of real-world evidence for evaluating anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration by Talks, James, Daien, Vincent, Finger, Robert P., Eldem, Bora, Sakamoto, Taiji, Cardillo, José Augusto, Mitchell, Paul, Wong, Tien Yin, Korobelnik, Jean-François

“…Randomized controlled trials are the gold standard in medical research, providing evidence of the efficacy of a treatment in well-defined patient populations…”
Get full text

Safety and efficacy of an artificial intelligence-enabled decision tool for treatment decisions in neovascular age-related macular degeneration and an exploration of clinical pathway integration and implementation: protocol for a multi-methods validation study by Hogg, Henry David Jeffry, Brittain, Katie, Teare, Dawn, Talks, James, Balaskas, Konstantinos, Keane, Pearse, Maniatopoulos, Gregory

“…IntroductionNeovascular age-related macular degeneration (nAMD) management is one of the largest single-disease contributors to hospital outpatient…”
Get full text

Comment on: Clinical outcomes in Caucasian patients with polypoidal choroidal vasculopathy by Hogg, H. D. Jeffry, Talks, S. James

Get full text

Measuring the benefit of 4 years of intravitreal ranibizumab treatment for neovascular age-related macular degeneration by Pushpoth, Sreekumari, Sykakis, Evripidis, Merchant, Kinnar, Browning, Andrew C, Gupta, Rajen, Talks, S James

“…To analyse the benefit of intravitreal ranibizumab over 4 years for patients with neovascular age-related macular degeneration (AMD). A retrospective case note…”
Get more information

A novel tool to assess the quality of RWE to guide the management of retinal disease by Finger, Robert P., Daien, Vincent, Talks, James S., Mitchell, Paul, Wong, Tien Y., Sakamoto, Taiji, Eldem, Bora M., Lövestam‐Adrian, Monica, Korobelnik, Jean‐François

“…Despite the growing importance of real‐world evidence (RWE) for guiding clinical decisions in retinal disease, there is currently no widely used guidance…”
Get full text

Developing an Evidence-Based Surgical Curriculum: Learning from a Randomized Controlled Trial of Surgical Rehearsal in Virtual Reality by Talks, Benjamin James, Lamtara, Jesslyn, Wijewickrema, Sudanthi, Collins, Aaron, Gerard, Jean-Marc, Mitchell-Innes, Alistair Macleold, O'Leary, Stephen

“…Surgical rehearsal - patient-specific preoperative surgical practice - can be provided by virtual reality simulation. This study investigated the effect of…”
Get full text

Stakeholder Perspectives on Clinical Decision Support Tools to Inform Clinical Artificial Intelligence Implementation: Protocol for a Framework Synthesis for Qualitative Evidence by Al-Zubaidy, Mohaimen, Hogg, H D Jeffry, Maniatopoulos, Gregory, Talks, James, Teare, Marion Dawn, Keane, Pearse A, R Beyer, Fiona

“…Quantitative systematic reviews have identified clinical artificial intelligence (AI)-enabled tools with adequate performance for real-world implementation. To…”
Get full text